STOCK TITAN

[144] Neuronetics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

STIM shareholder William A. Macan has filed a Form 144 notice to sell up to 14,120 shares of common stock. The proposed sale, with an aggregate market value of $23,241.52, is planned through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 02/12/2026.

The shares were acquired on 02/06/2026 through restricted stock vesting from the issuer as compensation. Over the prior three months, Macan sold 3,485 common shares for gross proceeds of $5,391.99. The filing also states that the seller represents having no undisclosed material adverse information about STIM.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Neuronetics

NASDAQ:STIM

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

108.21M
34.32M
9.44%
59.08%
8.87%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN